Baquiloprim-d₆

[1]. Lewicki J, et al. Oral bioavailability and pharmacokinetics of baquiloprim in dwarf goats. Research in veterinary science. 1995 May;58(3):268-71. [Content Brief]

[2]. White G, et al. Baquiloprim, a new antifolate antibacterial: in vitro activity and pharmacokinetic properties in cattle. Research in veterinary science. 1993 May;54(3):372-8. [Content Brief]

[3]. White DG, et al. Comparison of danofloxacin with baquiloprim/sulphadimidine for the treatment of experimentally induced Escherichia coli diarrhoea in calves. The Veterinary record. 1998 Sep 05;143(10):273-6. [Content Brief]

[4]. Davies AM, et al. Pharmacokinetics of baquiloprim and sulphadimidine in pigs after intramuscular administration. Research in veterinary science. 1994 Jul;57(1):69-74. [Content Brief]

[5]. Sunderland SJ, et al. Efficacy of danofloxacin 18% injectable solution in the treatment of Escherichia coli diarrhoea in young calves in Europe. Research in veterinary science. 2003 Apr;74(2):171-8. [Content Brief]

[6]. Dassanayake L, et al. Administration of a bolus formulation of baquiloprim and sulphadimidine to calves: plasma concentration--time profiles and efficacy in suppressing experimental pneumonic pasteurellosis. Veterinary microbiology. 1994 Jan;38(3):255-62. [Content Brief]